Appendix A: Results from concentration-response modeling of the data on zebrafish embryo test (ZET) of 9 petroleum substances (PS) extracts
Tab. A6: Results from a BMD analysis of the data on ZET of sample #172gas oil (GO)
The table presents the benchmark concentration for 50% effect on differentiation (BMC50) and the 95% benchmark dose lower confidence limit (BMCL50) values for a BMR of 10% extra risk with characteristics of the model fit. The selected model (BMC/BMCL < 3, lowest AIC) is given in bold.
Model type
Risk type 
BMFR Restricted model

No of parameters
Tab. A9: Results from a BMD analysis of the data on ZET of sample #186residual aromatic extract (RAE)
Model type
Risk type Appendix B: Results from dose-response modeling of the data on developmental toxicity occurring at higher incidences in petroleum substances exposed rats over controls (ARCO 1993; Feuston et al. 1996; Hoberman et al. 1995; Mobil 1989) 
BMFR Restricted model
No of parameters
Tab. B1: Results from a BMD analysis (continuous model) of the data on number of live fetuses/litter of female rats exposed to gas oil intermediate (64741-43-1) by dermal exposure on gestation days (GD) 0 to 19 (ARCO 1993)
The table presents the benchmark dose (BMD10) and the 95% benchmark dose lower confidence limit (BMDL10) values for a BMR of 1 standard deviation (SD) extra risk with characteristics of the model fit. The selected model (BMD/BMDL < 3, lowest AIC) is given in bold.
* BMD computation failed. Tab. B3: Results from a BMD analysis (continuous model) of the data on number of live fetuses/litter of female rats exposed to distillate aromatic extract (64742-04-7) by dermal exposure on gestation days (GD) 0 to 19 (Feuston et al.
Model type
1996)
Model type
Risk type BMFR Restricted Tab. B4: Results from a BMD analysis (continuous model) of the data on number of live fetuses/litter of female rats exposed to heavy fuel oil (64741-62-4) by dermal exposure on gestation days (GD) 0 to 19 (Hoberman et al., 1995) The table presents the benchmark dose (BMD10) and the 95% benchmark dose lower confidence limit (BMDL10) values for a BMR of 1 standard deviation (SD) extra risk with characteristics of the model fit. The selected model (BMD/BMDL < 3, lowest AIC) is given in bold.
Risk type BMFR Restricted Appendix C: Results from the ZET of samples tested in the present study: DMSO-extracts of 9 PS and 2 GTL products 0.25% (v/v) DMSO was used as solvent control for the ZET. The ZET results are presented as mean fraction of total general morphology scoring (GMS) system at 96 hpf. Results represent at least four independent experiments (n ≥ 4) and are presented as mean ± standard error mean (SEM).
Concentration
(µg raw material/ml) 
#034-HFO
Using BMC50s-ZET
Comparison of results when using either (A-D) the BMC50s-ZET, as determined using BMD software from US-EPA, or (E-H) the EC50s-ZET, as determined using GraphPad Prism 5.0; for the correlation analysis of the present study.
